Finance

Lists
Why is 001060 up 3,69%?
Dive Deeper
001060:KRX
JW Pharmaceutical Corp
25 300,00 KRW
+3,69%
(+900,00) 1D
16-окт., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001060...
Open
24 500 KRW
High
25 550 KRW
Low
24 500 KRW
Mkt. cap
607,55 млд
Avg. vol.
53,58 миң
Volume
0,00
Dividend
2,57%
Quarterly dividend
163 KRW
Ex-dividend date
2023-ж., 27-дек.
P/E ratio
6,03
52-wk high
39 250 KRW
52-wk low
21 550 KRW
EPS
4 193 KRW
Shares outstanding
23,29 млн
No. of employees
1 миң
Open
24 500 KRW
High
25 550 KRW
Low
24 500 KRW
Mkt. cap
607,55 млд
Avg. vol.
53,58 миң
Volume
0,00
Dividend
2,57%
Quarterly dividend
163 KRW
Ex-dividend date
2023-ж., 27-дек.
P/E ratio
6,03
52-wk high
39 250 KRW
52-wk low
21 550 KRW
EPS
4 193 KRW
Shares outstanding
23,29 млн
No. of employees
1 миң
News stories
From web sources and news partners
About JW Pharmaceutical Corp
CEOLee, Kyung Ha
Employees1,05 миң
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
200,02 млд
198,94 млд
199,88 млд
222,02 млд
Cost of goods sold
105,39 млд
109,09 млд
101,43 млд
116,73 млд
Cost of revenue
105,39 млд
109,09 млд
101,43 млд
116,73 млд
Research and development expenses
7,33 млд
15,27 млд
9,38 млд
11,86 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,58 млд
60,42 млд
55,91 млд
59,90 млд
Operating expense
62,60 млд
80,98 млд
64,88 млд
71,95 млд
Total operating expenses
167,99 млд
190,07 млд
166,31 млд
188,68 млд
Operating income
32,03 млд
8,87 млд
33,58 млд
33,34 млд
Other non operating income
-4,64 млд
8,03 млд
1,21 млд
835,27 млн
EBT including unusual items
27,85 млд
17,49 млд
35,20 млд
34,76 млд
EBT excluding unusual items
27,85 млд
15,96 млд
35,20 млд
34,76 млд
Income tax expense
-2,74 млд
2,18 млд
7,72 млд
6,86 млд
Effective tax rate
-9,83%
12,44%
21,93%
19,75%
Other operating expenses
-
-
-
-
Net income
30,59 млд
15,32 млд
27,48 млд
27,89 млд
Net profit margin
15,29%
7,70%
13,75%
12,56%
Earnings per share
1,27 миң
-
-
-
Interest and investment income
-
3,34 млд
-
-
Interest expense
-
-4,42 млд
-
-
Net interest expenses
-
-1,09 млд
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36,72 млд
13,65 млд
38,56 млд
38,37 млд
Gain or loss from assets sale
5,12 млн
3,00 миң
-10,00 млн
3,00 миң
AI content may include mistakes. Learn more
Google колдонмолору